DSpace logo
Please use this identifier to cite or link to this item: http://172.20.40.131:8080/jspui/handle/123456789/3508
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMehta, Maulin-
dc.contributor.authorPatharkar, Jayant-
dc.date.accessioned2021-10-19T14:35:01Z-
dc.date.available2021-10-19T14:35:01Z-
dc.date.issued2020-
dc.identifier.issn2250-1444-
dc.identifier.urihttp://172.20.40.131:80/jspui/handle/123456789/3508-
dc.description.abstractThe World Health Organization (WHO) introduced the term 2019 novel corona virus to refer to a corona virus that affected the lower respiratory tract of patients with pneumonia in Wuhan, China. The official name of the 2019 novel corona virus is corona virus disease (COVID-19), announced by WHO. The total reported cases of COVID-19 as of 15th June, 2020 are 79,95,877 and 4,35,598 reported deaths. Non-availability of vaccines and medicines for its treatment is really threatening to the world right now. All chloroquine and Hydroxychloroquine, antibacterial therapy like azithromycin and doxycycline, antiviral therapy like lopinavir/ritonavir and remdesivir, convalescent plasma therapy, zinc, vaccines and Tocilizumab are part of possible management options and none is officially approved for the treatment. Current review of various articles by searching on PubMed is initiated with intention of creating meaningful information regarding all possible management that is available or will be available in near future of COVID-19.en_US
dc.language.isoen_USen_US
dc.publisherAsian Journal of Pharmaceutical Research and Health Careen_US
dc.subjectConvalescent Plasma Therapyen_US
dc.subjectCorona-Virus Disease (COVID)-19en_US
dc.subjectHydroxychloroquineen_US
dc.subjectRemdesiviren_US
dc.subjectTocilizumaben_US
dc.subjectVaccineen_US
dc.titleCurrent Treatment Options Available for COVID-19 : A Reviewen_US
dc.typeArticleen_US
Appears in Collections:Faculty Publications

Files in This Item:
File Description SizeFormat 
Current Treatment Options Available for COVID-19 A Review.docx13.72 kBMicrosoft Word XMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.